| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pain | D010146 | 64 associated lipids |
| Lung Diseases | D008171 | 37 associated lipids |
| Burns | D002056 | 34 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Colitis | D003092 | 69 associated lipids |
| Fatty Liver | D005234 | 48 associated lipids |
| Pain, Postoperative | D010149 | 13 associated lipids |
| Peritonitis | D010538 | 38 associated lipids |
| Alzheimer Disease | D000544 | 76 associated lipids |
| Uveitis | D014605 | 14 associated lipids |
Resolvin d1
Resolvin d1 is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 305 references associated with Resolvin d1 in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for Resolvin d1
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Resolvin d1
PubChem Biomolecular Interactions and Pathways
All references with Resolvin d1
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| pmid: | ||||
| Serhan CN et al. | Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their aspirin-triggered endogenous epimers: an overview of their protective roles in catabasis. | 2004 | Prostaglandins Other Lipid Mediat. | pmid:15290791 |
| Hong S et al. | Resolvin D1, protectin D1, and related docosahexaenoic acid-derived products: Analysis via electrospray/low energy tandem mass spectrometry based on spectra and fragmentation mechanisms. | 2007 | J. Am. Soc. Mass Spectrom. | pmid:17055291 |
| Sun YP et al. | Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. | 2007 | J. Biol. Chem. | pmid:17244615 |
| Weylandt KH et al. | Lipoxins and resolvins in inflammatory bowel disease. | 2007 | Inflamm. Bowel Dis. | pmid:17262807 |
| Ariel A and Serhan CN | Resolvins and protectins in the termination program of acute inflammation. | 2007 | Trends Immunol. | pmid:17337246 |
| Haworth O and Levy BD | Endogenous lipid mediators in the resolution of airway inflammation. | 2007 | Eur. Respir. J. | pmid:17978156 |
| Chen Y et al. | Endogenous pro-resolving and anti-inflammatory lipid mediators: the new hope of atherosclerotic diseases. | 2008 | Med. Hypotheses | pmid:18448265 |
| Merched AJ et al. | Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. | 2008 | FASEB J. | pmid:18559988 |
| Serhan CN | Controlling the resolution of acute inflammation: a new genus of dual anti-inflammatory and proresolving mediators. | 2008 | J. Periodontol. | pmid:18673006 |
| Kasuga K et al. | Rapid appearance of resolvin precursors in inflammatory exudates: novel mechanisms in resolution. | 2008 | J. Immunol. | pmid:19050288 |
| Jin Y et al. | Anti-angiogenesis effect of the novel anti-inflammatory and pro-resolving lipid mediators. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19407006 |
| Spite M et al. | Resolvin D1 controls inflammation initiated by glutathione-lipid conjugates formed during oxidative stress. | 2009 | Br. J. Pharmacol. | pmid:19422383 |
| Wendel M and Heller AR | Anticancer actions of omega-3 fatty acids--current state and future perspectives. | 2009 | Anticancer Agents Med Chem | pmid:19442044 |
| Tian H et al. | Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. | 2009 | Invest. Ophthalmol. Vis. Sci. | pmid:19443724 |
| Kaarniranta K and Salminen A | NF-kappaB signaling as a putative target for omega-3 metabolites in the prevention of age-related macular degeneration (AMD). | 2009 | Exp. Gerontol. | pmid:19751815 |
| Filep JG | Lipid mediator interplay: resolvin D1 attenuates inflammation evoked by glutathione-conjugated lipid peroxidation products. | 2009 | Br. J. Pharmacol. | pmid:19845687 |
| Marcheselli VL et al. | Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. | 2010 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:19931440 |
| Krishnamoorthy S et al. | Resolvin D1 binds human phagocytes with evidence for proresolving receptors. | 2010 | Proc. Natl. Acad. Sci. U.S.A. | pmid:20080636 |
| Levy BD | Resolvins and protectins: natural pharmacophores for resolution biology. | 2010 Apr-Jun | Prostaglandins Leukot. Essent. Fatty Acids | pmid:20227865 |
| Xu ZZ et al. | Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions. | 2010 | Nat. Med. | pmid:20383154 |
| Yuan J et al. | The effects of polyunsaturated fatty acids and their metabolites on osteoclastogenesis in vitro. | 2010 | Prostaglandins Other Lipid Mediat. | pmid:20394833 |
| Sommer C and Birklein F | Fighting off pain with resolvins. | 2010 | Nat. Med. | pmid:20448572 |
| Bang S et al. | Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception. | 2010 | Br. J. Pharmacol. | pmid:20880407 |
| Recchiuti A et al. | MicroRNAs in resolution of acute inflammation: identification of novel resolvin D1-miRNA circuits. | 2011 | FASEB J. | pmid:20956612 |
| Huang L et al. | Enduring prevention and transient reduction of postoperative pain by intrathecal resolvin D1. | 2011 | Pain | pmid:21255928 |
| Schif-Zuck S et al. | Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. | 2011 | Eur. J. Immunol. | pmid:21268007 |
| Dartt DA et al. | Conjunctival goblet cell secretion stimulated by leukotrienes is reduced by resolvins D1 and E1 to promote resolution of inflammation. | 2011 | J. Immunol. | pmid:21357260 |
| Lima-Garcia JF et al. | The precursor of resolvin D series and aspirin-triggered resolvin D1 display anti-hyperalgesic properties in adjuvant-induced arthritis in rats. | 2011 | Br. J. Pharmacol. | pmid:21418187 |
| Norling LV et al. | Cutting edge: Humanized nano-proresolving medicines mimic inflammation-resolution and enhance wound healing. | 2011 | J. Immunol. | pmid:21460209 |
| Hellmann J et al. | Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese-diabetic mice. | 2011 | FASEB J. | pmid:21478260 |
| Wang B et al. | Resolvin D1 protects mice from LPS-induced acute lung injury. | 2011 | Pulm Pharmacol Ther | pmid:21501693 |
| Palmer CD et al. | 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli. | 2011 | J. Leukoc. Biol. | pmid:21653234 |
| Fredman G and Serhan CN | Specialized proresolving mediator targets for RvE1 and RvD1 in peripheral blood and mechanisms of resolution. | 2011 | Biochem. J. | pmid:21711247 |
| Bang S et al. | 17(R)-resolvin D1 specifically inhibits transient receptor potential ion channel vanilloid 3 leading to peripheral antinociception. | 2012 | Br. J. Pharmacol. | pmid:21718307 |
| Bento AF et al. | Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. | 2011 | J. Immunol. | pmid:21724996 |
| Ji RR et al. | Emerging roles of resolvins in the resolution of inflammation and pain. | 2011 | Trends Neurosci. | pmid:21963090 |
| Titos E et al. | Resolvin D1 and its precursor docosahexaenoic acid promote resolution of adipose tissue inflammation by eliciting macrophage polarization toward an M2-like phenotype. | 2011 | J. Immunol. | pmid:22013115 |
| Park CK et al. | Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1. | 2011 | J. Neurosci. | pmid:22171045 |
| Odusanwo O et al. | Resolvin D1 prevents TNF-α-mediated disruption of salivary epithelial formation. | 2012 | Am. J. Physiol., Cell Physiol. | pmid:22237406 |
| Widgerow AD | Cellular resolution of inflammation--catabasis. | 2012 Jan-Feb | Wound Repair Regen | pmid:22276585 |
| Krishnamoorthy S et al. | Resolvin D1 receptor stereoselectivity and regulation of inflammation and proresolving microRNAs. | 2012 | Am. J. Pathol. | pmid:22449948 |
| Norling LV et al. | Resolvin D1 limits polymorphonuclear leukocyte recruitment to inflammatory loci: receptor-dependent actions. | 2012 | Arterioscler. Thromb. Vasc. Biol. | pmid:22499990 |
| Chiang N et al. | Infection regulates pro-resolving mediators that lower antibiotic requirements. | 2012 | Nature | pmid:22538616 |
| pmid:22610993 | ||||
| Eickmeier O et al. | Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. | 2013 | Mucosal Immunol | pmid:22785226 |
| Rogerio AP et al. | Resolvin D1 and aspirin-triggered resolvin D1 promote resolution of allergic airways responses. | 2012 | J. Immunol. | pmid:22802419 |
| Clà ria J et al. | Resolvin D1 and resolvin D2 govern local inflammatory tone in obese fat. | 2012 | J. Immunol. | pmid:22844113 |
| Dalli J and Serhan CN | Specific lipid mediator signatures of human phagocytes: microparticles stimulate macrophage efferocytosis and pro-resolving mediators. | 2012 | Blood | pmid:22904297 |
| Mas E et al. | Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. | 2012 | Clin. Chem. | pmid:22912397 |
| Martin N et al. | Primary human airway epithelial cell-dependent inhibition of human lung mast cell degranulation. | 2012 | PLoS ONE | pmid:22970103 |
| Tang Y et al. | Proresolution therapy for the treatment of delayed healing of diabetic wounds. | 2013 | Diabetes | pmid:23043160 |
| Quan-Xin F et al. | Resolvin D1 reverses chronic pancreatitis-induced mechanical allodynia, phosphorylation of NMDA receptors, and cytokines expression in the thoracic spinal dorsal horn. | 2012 | BMC Gastroenterol | pmid:23092159 |
| Jones CN et al. | Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions. | 2012 | Proc. Natl. Acad. Sci. U.S.A. | pmid:23185003 |
| Mizwicki MT et al. | 1α,25-dihydroxyvitamin D3 and resolvin D1 retune the balance between amyloid-β phagocytosis and inflammation in Alzheimer's disease patients. | 2013 | J. Alzheimers Dis. | pmid:23186989 |
| Liao Z et al. | Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway. | 2012 | Respir. Res. | pmid:23199346 |
| Chung ML et al. | Profiling of oxidized lipid products of marine fish under acute oxidative stress. | 2013 | Food Chem. Toxicol. | pmid:23220612 |
| Settimio R et al. | Resolvin D1 reduces the immunoinflammatory response of the rat eye following uveitis. | 2012 | Mediators Inflamm. | pmid:23304060 |
| Khaled M et al. | Effects of resolvin D1 on cell survival and cytokine expression of human gingival fibroblasts. | 2013 | J. Periodontol. | pmid:23398023 |
| Miyahara T et al. | D-series resolvin attenuates vascular smooth muscle cell activation and neointimal hyperplasia following vascular injury. | 2013 | FASEB J. | pmid:23407709 |
| Kurihara T et al. | Resolvin D2 restores neutrophil directionality and improves survival after burns. | 2013 | FASEB J. | pmid:23430978 |
| Li D et al. | Resolvin D1 and aspirin-triggered resolvin D1 regulate histamine-stimulated conjunctival goblet cell secretion. | 2013 | Mucosal Immunol | pmid:23462912 |
| Hsiao HM et al. | A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. | 2013 | PLoS ONE | pmid:23484005 |
| Recchiuti A | Resolvin D1 and its GPCRs in resolution circuits of inflammation. | 2013 | Prostaglandins Other Lipid Mediat. | pmid:23500003 |
| Xu MX et al. | Resolvin D1, an endogenous lipid mediator for inactivation of inflammation-related signaling pathways in microglial cells, prevents lipopolysaccharide-induced inflammatory responses. | 2013 | CNS Neurosci Ther | pmid:23521911 |
| Koltsida O et al. | Toll-like receptor 7 stimulates production of specialized pro-resolving lipid mediators and promotes resolution of airway inflammation. | 2013 | EMBO Mol Med | pmid:23584892 |
| Terrando N et al. | Aspirin-triggered resolvin D1 prevents surgery-induced cognitive decline. | 2013 | FASEB J. | pmid:23709617 |
| Dalli J et al. | Novel n-3 immunoresolvents: structures and actions. | 2013 | Sci Rep | pmid:23736886 |
| Lee HN et al. | Resolvin D1 stimulates efferocytosis through p50/p50-mediated suppression of tumor necrosis factor-α expression. | 2013 | J. Cell. Sci. | pmid:23788426 |
| Zhang X et al. | Resolvin D1 protects podocytes in adriamycin-induced nephropathy through modulation of 14-3-3β acetylation. | 2013 | PLoS ONE | pmid:23840712 |
| Lee HN and Surh YJ | Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis. | 2013 | Biochem. Pharmacol. | pmid:23856291 |
| Xie W et al. | Resolvin D1 reduces deterioration of tight junction proteins by upregulating HO-1 in LPS-induced mice. | 2013 | Lab. Invest. | pmid:23857007 |
| Mustafa M et al. | Resolvin D1 protects periodontal ligament. | 2013 | Am. J. Physiol., Cell Physiol. | pmid:23864609 |
| Chen F et al. | Resolvin D1 improves survival in experimental sepsis through reducing bacterial load and preventing excessive activation of inflammatory response. | 2014 | Eur. J. Clin. Microbiol. Infect. Dis. | pmid:24072678 |
| Abdelmoaty S et al. | Spinal actions of lipoxin A4 and 17(R)-resolvin D1 attenuate inflammation-induced mechanical hypersensitivity and spinal TNF release. | 2013 | PLoS ONE | pmid:24086560 |
| Lee HJ et al. | Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32. | 2013 | Int. J. Biochem. Cell Biol. | pmid:24120851 |
| Wu D et al. | Novel biphasic role of resolvin D1 on expression of cyclooxygenase-2 in lipopolysaccharide-stimulated lung fibroblasts is partly through PI3K/AKT and ERK2 pathways. | 2013 | Mediators Inflamm. | pmid:24174713 |
| Rius B et al. | Resolvin D1 primes the resolution process initiated by calorie restriction in obesity-induced steatohepatitis. | 2014 | FASEB J. | pmid:24249635 |
| Nelson JW et al. | ALX/FPR2 receptor for RvD1 is expressed and functional in salivary glands. | 2014 | Am. J. Physiol., Cell Physiol. | pmid:24259417 |
| Zhang X et al. | Resolvin D1 reverts lipopolysaccharide-induced TJ proteins disruption and the increase of cellular permeability by regulating IκBα signaling in human vascular endothelial cells. | 2013 | Oxid Med Cell Longev | pmid:24381712 |
| Yaxin W et al. | Resolvin D1 attenuates lipopolysaccharide induced acute lung injury through CXCL-12/CXCR4 pathway. | 2014 | J. Surg. Res. | pmid:24387839 |
| Leigh NJ et al. | Expression of resolvin D1 biosynthetic pathways in salivary epithelium. | 2014 | J. Dent. Res. | pmid:24389810 |
| Sun YB et al. | Endothelial dysfunction exacerbates renal interstitial fibrosis through enhancing fibroblast Smad3 linker phosphorylation in the mouse obstructed kidney. | 2013 | PLoS ONE | pmid:24391884 |
| pmid:24451959 | ||||
| Wang X et al. | Resolution of inflammation is altered in Alzheimer's disease. | 2015 | Alzheimers Dement | pmid:24530025 |
| pmid:24571866 | ||||
| Aursnes M et al. | Total synthesis of the lipid mediator PD1n-3 DPA: configurational assignments and anti-inflammatory and pro-resolving actions. | 2014 | J. Nat. Prod. | pmid:24576195 |
| Wang Q et al. | Resolvin D1 stimulates alveolar fluid clearance through alveolar epithelial sodium channel, Na,K-ATPase via ALX/cAMP/PI3K pathway in lipopolysaccharide-induced acute lung injury. | 2014 | J. Immunol. | pmid:24646745 |
| Recchiuti A et al. | Immunoresolving actions of oral resolvin D1 include selective regulation of the transcription machinery in resolution-phase mouse macrophages. | 2014 | FASEB J. | pmid:24692596 |
| Li L et al. | Resolvin D1 promotes the interleukin-4-induced alternative activation in BV-2 microglial cells. | 2014 | J Neuroinflammation | pmid:24708771 |
| Chen J et al. | Aspirin-triggered resolvin D1 down-regulates inflammatory responses and protects against endotoxin-induced acute kidney injury. | 2014 | Toxicol. Appl. Pharmacol. | pmid:24709673 |
| pmid:24784707 | ||||
| Mirakaj V et al. | Vagus nerve controls resolution and pro-resolving mediators of inflammation. | 2014 | J. Exp. Med. | pmid:24863066 |
| McCauley LK et al. | Cutting edge: Parathyroid hormone facilitates macrophage efferocytosis in bone marrow via proresolving mediators resolvin D1 and resolvin D2. | 2014 | J. Immunol. | pmid:24890726 |
| Martin CR et al. | Resolvin D1 and lipoxin A4 improve alveolarization and normalize septal wall thickness in a neonatal murine model of hyperoxia-induced lung injury. | 2014 | PLoS ONE | pmid:24892762 |
| pmid:24929111 | ||||
| pmid:25030943 | ||||
| pmid:25123641 | ||||
| Hua J et al. | The resolvin D1 analogue controls maturation of dendritic cells and suppresses alloimmunity in corneal transplantation. | 2014 | Invest. Ophthalmol. Vis. Sci. | pmid:25146982 |
| Tang H et al. | Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury. | 2014 | J. Immunol. | pmid:25172497 |